Abstract | PURPOSE: Two viral oncoproteins, E6 and E7, are expressed in all human papillomavirus (HPV)-infected cells, from initial infection in the genital tract to metastatic cervical cancer. Intramuscular vaccination of women with high-grade cervical intraepithelial neoplasia (CIN2/3) twice with a naked DNA vaccine, pNGVL4a-sig/E7(detox)/HSP70, and a single boost with HPVE6/E7 recombinant vaccinia vaccine (TA-HPV) elicited systemic HPV-specific CD8 T-cell responses that could traffic to the lesion and was associated with regression in some patients (NCT00788164). EXPERIMENTAL DESIGN: Here, we examine whether alteration of this vaccination regimen by administration of TA-HPV vaccination in the cervicovaginal tract, rather than intramuscular (IM) delivery, can more effectively recruit antigen-specific T cells in an orthotopic syngeneic mouse model of HPV16(+) cervical cancer (TC-1 luc). RESULTS: We found that pNGVL4a-sig/E7(detox)/HSP70 vaccination followed by cervicovaginal vaccination with TA-HPV increased accumulation of total and E7-specific CD8(+) T cells in the cervicovaginal tract and better controlled E7-expressing cervicovaginal TC-1 luc tumor than IM administration of TA-HPV. Furthermore, the E7-specific CD8(+) T cells in the cervicovaginal tract generated through the cervicovaginal route of vaccination expressed the α4β7 integrin and CCR9, which are necessary for the homing of the E7-specific CD8(+) T cells to the cervicovaginal tract. Finally, we show that cervicovaginal vaccination with TA-HPV can induce potent local HPV-16 E7 antigen-specific CD8(+) T-cell immune responses regardless of whether an HPV DNA vaccine priming vaccination was administered IM or within the cervicovaginal tract. CONCLUSIONS: Our results support future clinical translation using cervicovaginal TA-HPV vaccination.
|
Authors | Yun-Yan Sun, Shiwen Peng, Liping Han, Jin Qiu, Liwen Song, Yachea Tsai, Benjamin Yang, Richard B S Roden, Cornelia L Trimble, Chien-Fu Hung, T-C Wu |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 22
Issue 3
Pg. 657-69
(Feb 01 2016)
ISSN: 1557-3265 [Electronic] United States |
PMID | 26420854
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Copyright | ©2015 American Association for Cancer Research. |
Chemical References |
- Biomarkers
- Papillomavirus E7 Proteins
- Papillomavirus Vaccines
- Vaccines, DNA
- human papillomavirus vaccine, TA
|
Topics |
- Animals
- Biomarkers
- CD8-Positive T-Lymphocytes
(immunology, metabolism)
- Chemotaxis, Leukocyte
(immunology)
- Dendritic Cells
(immunology, metabolism)
- Disease Models, Animal
- Female
- Genital Neoplasms, Female
(etiology, mortality, prevention & control)
- Humans
- Immunization
- Immunization, Secondary
- Immunophenotyping
- Mice
- Mice, Knockout
- Papillomaviridae
(genetics, immunology)
- Papillomavirus E7 Proteins
(immunology)
- Papillomavirus Infections
(complications, prevention & control)
- Papillomavirus Vaccines
(administration & dosage, immunology)
- Phenotype
- Vaccines, DNA
(administration & dosage, immunology)
|